107 related articles for article (PubMed ID: 15977240)
1. The impact of high risk human papillomavirus testing in an inner London colposcopy clinic.
Perrons C; Brink N; Jalal H; Watts P; Jelley R
J Med Virol; 2005 Aug; 76(4):576-82. PubMed ID: 15977240
[TBL] [Abstract][Full Text] [Related]
2. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic.
Perrons C; Kleter B; Jelley R; Jalal H; Quint W; Tedder R
J Med Virol; 2002 Jun; 67(2):246-52. PubMed ID: 11992586
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus absence predicts normal cervical histopathologic findings with abnormal papanicolaou smears: a study of a university-based inner city population.
Khanna N; Brooks SE; Chen TT; Simsir A; Gordon NJ; Taylor G
J Hum Virol; 2001; 4(5):283-7. PubMed ID: 11907386
[TBL] [Abstract][Full Text] [Related]
4. The role of HPV testing in patients with possible high-grade cervical cytology.
Rao A; Pather S; Dalrymple C; Mackie A; Deans R; Carter J
J Obstet Gynaecol Res; 2009 Jun; 35(3):503-6. PubMed ID: 19527390
[TBL] [Abstract][Full Text] [Related]
5. Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA.
Perrons C; Jelley R; Kleter B; Quint W; Brink N
J Clin Virol; 2005 Apr; 32(4):278-85. PubMed ID: 15780805
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.
Agarossi A; Ferrazzi E; Parazzini F; Perno CF; Ghisoni L
J Med Virol; 2009 Mar; 81(3):529-35. PubMed ID: 19152401
[TBL] [Abstract][Full Text] [Related]
7. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells.
Saqi A; Gupta PK; Erroll M; Babiac A; Blackmun D; Mansukhani M; Vazquez M
Diagn Cytopathol; 2006 Mar; 34(3):235-9. PubMed ID: 16470857
[TBL] [Abstract][Full Text] [Related]
8. Detection of human papillomavirus infection in women attending a colposcopy clinic.
Selva L; Gonzalez-Bosquet E; Rodriguez-Plata MT; Esteva C; Suñol M; Muñoz-Almagro C
Diagn Microbiol Infect Dis; 2009 Aug; 64(4):416-21. PubMed ID: 19376675
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of HPV 16 PCR detection in self- compared with clinician-collected samples in women referred for colposcopy.
Daponte A; Pournaras S; Mademtzis I; Hadjichristodoulou C; Kostopoulou E; Maniatis AN; Messinis IE
Gynecol Oncol; 2006 Nov; 103(2):463-6. PubMed ID: 16626791
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
11. Epidemiologic correlates of cervical human papillomavirus prevalence in women with abnormal Pap smear tests: a Taiwan Cooperative Oncology Group (TCOG) study.
Sun CA; Hsiung CA; Lai CH; Chen CA; Chou CY; Ho CM; Twu NF; Feng WL; Chuang MH; Hsieh CY; Chu TY
J Med Virol; 2005 Oct; 77(2):273-81. PubMed ID: 16121376
[TBL] [Abstract][Full Text] [Related]
12. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
Cibas ES; Hong X; Crum CP; Feldman S
Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
[TBL] [Abstract][Full Text] [Related]
13. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results.
Muñoz N; Méndez F; Posso H; Molano M; van den Brule AJ; Ronderos M; Meijer C; Muñoz A;
J Infect Dis; 2004 Dec; 190(12):2077-87. PubMed ID: 15551205
[TBL] [Abstract][Full Text] [Related]
14. Anal human papillomavirus DNA in women at a colposcopy clinic.
D'Hauwers KW; Cornelissen T; Depuydt CE; Bogers J; Donders AR; Leuridan E; Van Damme P; Tjalma WA
Eur J Obstet Gynecol Reprod Biol; 2012 Sep; 164(1):69-73. PubMed ID: 22677508
[TBL] [Abstract][Full Text] [Related]
15. [Study for association between high risk human papillomavirus and cervical lesions in the samples from opportunistic screening].
Bian LH; Li Y; Wang XL; Wu XZ; Song L; Liu HT
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):89-91. PubMed ID: 21863625
[TBL] [Abstract][Full Text] [Related]
16. Subvisual chromatin changes in cervical epithelium measured by texture image analysis and correlated with HPV.
Guillaud M; Adler-Storthz K; Malpica A; Staerkel G; Matisic J; Van Niekirk D; Cox D; Poulin N; Follen M; Macaulay C
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S16-23. PubMed ID: 16188299
[TBL] [Abstract][Full Text] [Related]
17. Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa.
Marais DJ; Passmore JA; Denny L; Sampson C; Allan BR; Williamson AL
J Med Virol; 2008 Jun; 80(6):953-9. PubMed ID: 18428143
[TBL] [Abstract][Full Text] [Related]
18. HPV DNA testing in the triage of atypical squamous cells of undetermined significance (ASCUS): cost comparison of two methods.
Layfield LJ; Qureshi MN
Diagn Cytopathol; 2005 Aug; 33(2):138-43. PubMed ID: 16007672
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.
Bao YP; Li N; Smith JS; Qiao YL
Int J STD AIDS; 2008 Feb; 19(2):106-11. PubMed ID: 18334063
[TBL] [Abstract][Full Text] [Related]
20. A peer comparison program for the quality assurance of human papillomavirus DNA detection using the Digene Hybrid Capture II/SurePath method shows excellent analytic interlaboratory correlation.
Kuebler DL; Illingworth A; Blenc AM; Wilbur DC
Cancer; 2007 Oct; 111(5):339-43. PubMed ID: 17879373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]